checkAd

     234  0 Kommentare Zomedica Appoints New Interim CEO to Lead Organization Through Inaugural Product Launch - Seite 3



    The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. Readers are cautioned not to place undue reliance on forward-looking information.

    Investor Relations Contact:
    PCG Advisory Group
    Kirin Smith, COO
    ksmith@pcgadvisory.com
    +1 646.863.6519

    Media Contact:
    Meredith Newman
    mnewman@zomedica.com
    +1 734.369.2555 ext. 119


    Lesen Sie auch


    globenewswire
    0 Follower
    Autor folgen
    Seite 3 von 3

    Verfasst von globenewswire
    Zomedica Appoints New Interim CEO to Lead Organization Through Inaugural Product Launch - Seite 3 Moves Closer to Development Completion of Its Novel Point-of-Care Diagnostic PlatformANN ARBOR, Mich., June 16, 2020 (GLOBE NEWSWIRE) - Zomedica Pharmaceuticals Corp. (“Zomedica” or the “Company”) (NYSE American: ZOM), a veterinary diagnostic …

    Schreibe Deinen Kommentar

    Disclaimer